Clinical Trials
1,141 trialsMultimodal Machine Learning Characterization of Solid Tumors
Massachusetts General Hospital
A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular Carcinoma
Shandong Cancer Hospital and Institute
Neoadjuvant Nivolumab With CCR2/5-inhibitor or Anti-IL-8) for Non-small Cell Lung Cancer (NSCLC) or Hepatocellular Carcinoma (HCC)
Icahn School of Medicine at Mount Sinai
SBS-CEUS
The First Hospital of Jilin University
A Study of Recombinant Vaccinia Virus to Evaluate the Safety and Efficacy of a Transdermal Injection Within the Tumor of Patients With Primary or Metastatic Hepatic Carcinoma
SillaJen, Inc.
Hepatocellular
The University of Hong Kong
NARFI
University Hospital, Bordeaux
CIRT
Cardiovascular and Interventional Radiological Society of Europe
LEAP-012
Merck Sharp & Dohme LLC
Study of Y90-Radioembolization With Nivolumab in Asians With Hepatocellular Carcinoma
National Cancer Centre, Singapore
Standing Position Ultrasonography: Imaging Efficacy in Detecting Liver Diaphragmatic Dome Blind Area Lesions
The First Hospital of Jilin University
Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/Tyrosine Kinase Inhibitors With or Without HAIC for Unresectable HCC With Portal Vein Tumor Thrombosis
Zhongda Hospital
Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/Tyrosine Kinase Inhibitors With or Without TACE for Advanced HCC With Vascular Invasions
Zhongda Hospital
Phase II Study of PRL3-ZUMAB in Advanced Solid Tumors
National Cancer Centre, Singapore
Radiotherapy Delays Second-line Drug Therapy for Oligo Progressive Primary Liver Cancer
Shandong Cancer Hospital and Institute
HCC
Anhui Provincial Hospital
Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants
Mayo Clinic
KEYNOTE-937
Merck Sharp & Dohme LLC
MAGNUS-HCC
Seoul St. Mary's Hospital
Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion
Samsung Medical Center
Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
Montefiore Medical Center
CHANCE2202
Zhongda Hospital
CHANCE2201
Zhongda Hospital
Phase II Study of Moderate-dose Hypofractionated RT Combined With Tislelizumab for HCC With Diffuse Tumor Thrombosis
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
FRI-STC
National Hepatology & Tropical Medicine Research Institute
TraveraRTGx
Travera Inc
Clinical Feasibility of Microwave Ablation Using Two Channel Microwave Generator and Two Antennas for Small Hepatocellular Carcinoma
Seoul National University Hospital
ERFA
Seoul National University Hospital
LIVERAL
ANRS, Emerging Infectious Diseases
Lipiocis
ANRS, Emerging Infectious Diseases
TORCH
Sun Yat-sen University
VOCAL
Imperial College London
Development of a Neuronal Microscope
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Evaluating the Effects of Selective Treatment Utilizing Flex-dosing for Unresectable HCC With Y90 SIR-Spheres
Methodist Health System
IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
A Study to Compare the Effectiveness and Safety of IBI310 Combined With Sintilimab Versus Sorafenib in the First-line Treatment of Advanced HCC
Innovent Biologics (Suzhou) Co. Ltd.
Alectinib in Combination With Nivolumab in the Treatment of Recurrent or Refractory HCC Patients Guided With Serum RNase1 and Tumor Expression of PD-L1
China Medical University Hospital
Individualized Surgical Guidance in HCC-BDTT
First Affiliated Hospital, Sun Yat-Sen University
Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma
Coherus Oncology, Inc.
CKNO-HEP
Centre Oscar Lambret
SEEK
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
TRIPLET
Federation Francophone de Cancerologie Digestive
A Study of AK112 in Patients With Unresectable Hepatocellular Carcinoma (HCC)
Akeso
CECT Features of MVI Predict Response to TACE Plus TKI in Intermediate-stage HCC
First Affiliated Hospital, Sun Yat-Sen University
Hepatic Artery Infusion Chemotherapy (HAIC) Plus Durvalumab for Advanced Hepatocellular Carcinoma
Sun Yat-sen University
SBRT for Liver Tumors, Liver Metastases, and Pancreatic Tumors
Institute of Oncology Ljubljana
Effect of Pre-Transplant Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma Patients With Liver Transplantation
First Affiliated Hospital Xi'an Jiaotong University
A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Apatinib in Patients With Advanced HCC(RESCUE)
Jiangsu HengRui Medicine Co., Ltd.
CISLD-8
Zhejiang University
Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis
University of California, San Diego